Mechanical circulatory support and cardiac transplantation

Circulation

Volumn 97, Issue 20, 1998, Pages 2079-2090

  Hunt, Sharon A ^b   Frazier, O H ^a   Myers, Timothy J ^a  

^a TEXAS HEART INSTITUTE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Heart assist device; Survival; Transplantation

Indexed keywords

ALLOGRAFT; ARTIFICIAL HEART; ASSISTED CIRCULATION; ATHEROSCLEROSIS; BLEEDING; COMPARATIVE STUDY; CONGENITAL HEART DISEASE; CONGESTIVE HEART FAILURE; DEVICE; HEART GRAFT; HUMAN; INFECTION; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SURVIVAL RATE; TREATMENT INDICATION; VALVULAR HEART DISEASE;

EID: 0032568489     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.20.2079     Document Type: Review

References (103)

1. American Heart Association. Heart and Stroke Facts: Statistical Supplement. Dallas, Tex: American Heart Association; 1998.
2. O'Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant. 1994;13(suppl):S107-S112.
3. Cohn JN. The management of chronic heart failure. N Engl J Med. 1996;335:490-498.
4. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med. 1991;325:293-302.
5. Packer M, Bristow MR, Cohn JR, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349-1355.
6. Funk D. Epidemiology of end-stage heart disease. In: Committee to Evaluate the Artificial Heart Program of the National Heart, Lung, and Blood Institute. The Artificial Heart: Prototypes, Policies and Patients. Washington, DC: National Academy Press; 1991:251.
7. Gibbon JH. Application of a heart and lung apparatus to cardiac surgery. Minn Med. 1954;37:171-180.
8. Kantrowitz A, Tjonneland S, Freed PS, Phillips SJ, Butner AN, Sherman JL Jr. Initial clinical experience with the intraaortic balloon pumping in cardiogenic shock. JAMA. 1968;203:113-118.
9. Dennis C. Left heart bypass. In: Mechanical Devices to Assist the Failing Heart. Washington, DC: National Academy of Sciences-National Research Council; 1966:27. Publication No. 1283.
10. Spencer FD, Eiseman B, Trinkle JK, Ross NP. Assisted circulation for cardiac failure following intra-cardiac surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1965;49:56.
11. DeBakey ME, Liotta D, Hall CW. Left heart bypass using an implantable blood pump. In: Mechanical Devices to Assist the Failing Heart: Proceedings of a Conference Sponsored by The Committee on Trauma, September 9-10, 1964. Washington. DC: National Academy of Sciences-National Research Council; 1966:223.
12. Cooley DA, Liotta D, Hallman GL, Bloodwell RD, Leachman RD, Milam JD. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol. 1969;24:723-730.
13. Rose EA, Levin HR, Oz MC, Frazier OH, Macmanus Q, Burton NA, Lefrak EA. Artificial circulatory support with textured interior surfaces: a counterintuitive approach to minimizing thromboembolism. Circulation. 1994;90(pt 2):II-87-II-91.
14. Graham TR, Dasse K, Coumbe A, Salih V, Marrinan MT, Frazier OH, Lewis CT. Neo-intimal development on textured biomaterial surfaces during clinical use of an implantable left ventricular assist device. Eur J Cardiothorac Surg. 1990;4:182-190.
15. McGee MG, Myers TJ, Abou-Awdi N, Dasse KA, Radovancevic B, Lonquist JL, Duncan JM, Frazier OH. Extended support with a left ventricular assist device as a bridge to heart transplantation. ASAIO Trans. 1991;37:M425-M426.
16. Poirier VL, Frazier OH. Portable electric systems for long-term use. In: Akutsu T, Koyanagi H, eds. Heart Replacement: Artificial Heart 4. Tokyo, Japan: Springer-Verlag; 1993:103-114.
17. Radovancevic B, Frazier OH, Duncan JM. Implantation technique for the HeartMate left ventricular assist device. J Card Surg. 1992;7: 203-207.
18. McCarthy PM, Wang N, Vargo R. Preperitoneal insertion of the HeartMate 1000 IP implantable left ventricular assist device. Ann Thorac Surg. 1994;57:634-638.
19. Myers TJ, Catanese KA, Vargo RL, Dressler DK. Extended cardiac support with a portable left ventricular assist system in the home. ASAIO J. 1996;42:M576-M579.
20. Shinn JA, Oyer PE. Novacor ventricular assist system. In: Qual SJ, ed. Cardiac Mechanical Assistance Beyond Balloon Pumping. St Louis, Mo: CV Mosby; 1993:99.
21. Miller PJ, Billich TJ, LaForge DH, Lee J, Naegeli A, Ramasamy N, Jassawalla JS, Portner PM. Initial clinical experience with a wearable controller for the Novacor left ventricular assist system. ASAIO J. 1994;40:M465-M470.
22. Pennington DG, McBride LR, Swartz MT. Implantation technique for the Novacor left ventricular assist system. J Thorac Cardiovasc Surg. 1994;108:604-608.
23. Pristas JM, Winowich S, Nastala CJ, Gifford J, Conner EA, Borovetz HS, Griffith BP, Portner PM, Kormos RL. Protocol for releasing Novacor left ventricular assist system patients out-of-hospital. ASAIO J. 1995;41:M539-M543.
24. Farrar DJ, Hill JD. Univentricular and biventricular Thoratec VAD support as a bridge to transplantation. Ann Thorac Surg. 1993;55: 276-282.
25. Ley SJ, Hill JD. Thoratec ventricular assist device. In: Qual SJ, ed. Cardiac Mechanical Assistance Beyond Balloon Pumping. St Louis, Mo: CV Mosby; 1993:67.
26. Reedy JE, Swartz MT, Lohmann DP, Moroney DA, Vaca KJ, McBride LR, Pennington DG. The importance of patient mobility with ventricular assist device support. ASAIO J. 1992;38:M15I-M153.
27. Copeland JG, Pavie A, Duveau D, Keon WJ, Masters R, Pifarre R, Smith RG, Arabia FA. Bridge to transplantation with the CardioWest total artificial heart: the international experience 1993 to 1995. J Heart Lung Transplant. 1996;15(pt 1):94-99.
28. Arabia FA, Smith RG, Rose DS, Arzouman DA, Sethi GK, Copeland JG. Success rates of long-term circulatory assist devices used currently for bridge to heart transplantation. ASAIO J. 1996;42:M542-M546.
29. Slater JP, Rose EA, Levin HR, Frazier OH, Roberts JK, Weinberg AD, Oz MC. Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices. Ann Thorac Surg. 1996; 62:1321-1327.
30. Quaini E, Pavie A, Chieco S, Mambrito B. The Concerted Action "Heart" European registry on clinical application of mechanical circulatory support systems: bridge to transplant: the Registry Scientific Committee. Eur J Cardiothorac Surg. 1997;11:182-188.
31. Mehta SM, Aufiero TX, Pae WE Jr, Miller CA, Pierce WS. Combined Registry for the Clinical Use of Mechanical Ventricular Assist Pumps and the Total Artificial Heart in conjunction with heart transplantation: sixth official report-1994. J Heart Lung Transplant. 1995;14:585-593.
32. Frazier OH, Rose EA, McCarthy P, Burton NA, Tector A, Levin H, Kayne HL, Poirier VL, Dasse KA, Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg. 1995;222:327-336.
33. Kormos RL, Murali S, Dew MA, Armitage JM, Hardesty RL, Borovetz HS, Griffith BP. Chronic mechanical circulatory support: rehabilitation, low morbidity, and superior survival. Ann Thorac Surg. 1994;57:51-58.
34. Frazier OH, Maoris MP, Myers TJ, Duncan JM, Radovancevic B, Parnis SM, Cooley DA. Improved survival after extended bridge to cardiac transplantation. Ann Thorac Surg. 1994;57:1416-1422.
35. Livingston ER, Fisher CA, Bibidakis EJ, Pathak AS, Todd BA, Furukawa S, McClurken JB, Addonizio VP, Jeevanandam V. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. Circulation. 1996;94(suppl II):II-227-II-234.
36. Johnson KE, Prieto M, Joyce LD, Pritzker M, Emery RW. Summary of the clinical use of the Symbion total artificial heart: a registry report. Ann Surg. 1995;222:327-336.
37. Moroney DA, Vaca KJ. Infectious complications associated with ventricular assist devices. Am J Crit Care. 1995;4:204-209.
38. Holman WL, Murrah CP, Ferguson ER, Bourge RC, McGiffin DC, Kirklin JK. Infections during extended circulatory support: University of Alabama at Birmingham experience 1989 to 1994. Ann Thorac Surg. 1996;61:366-371.
39. McBride LR, Swartz MT, Reedy JE, Miller LW, Pennington DG. Device related infections in patients supported with mechanical circulatory support devices for greater than 30 days, ASAIO Trans. 1991;37: M258-M259.
40. Myers TJ, McGee MG, Zeluff BJ, Radovancevic B, Frazier OH. Frequency and significance of infections in patients receiving prolonged LVAD support. ASAIO Trans. 1991;37:M283-M285.
41. Herrmann M, Weyand M, Greshake B, von Eiff C, Proctor RA, Scheid HH, Peters G. Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation. 1997;95:814-817.
42. Springer WE, Wasler A, Radovancevic B, Myers T, Odegaard P, Macris MP, Frazier OH. Retrospective analysis of infection in patients undergoing support with left ventricular assist systems. ASAIO J. 1996; 42:M763-M765.
43. McCarthy PM, Schmitt SK, Vargo RL, Gordon S, Keys TF, Hobbs RE. Implantable LVAD infections: implications for permanent use of the device. Ann Thorac Surg. 1996;61:359-365.
44. Mehta SM, Boehmer JP, Pae WE Jr, Aufiero TX, Davis D, Pierce WS. Bridging to transplant: equal extended survival for patients undergoing LVAD support when compared with long-term medical management. ASAIO J. 1996;42:M406-M410.
45. Magovern GJ, Golding LA, Oyer PE, Cabrol C. Circulatory support 1988: weaning and bridging. Ann Thorac- Surg. 1989;47:102-107.
46. Shapiro PA, Levin HR, Oz MC. Left ventricular assist devices: psychosocial burden and implications for heart transplant programs. Gen Hosp Psychiatry. 1996;18(suppl):30S-35S.
47. Dew MA, Kormos RL, Roth LH, Armitage JM, Pristas JM, Harris RC, Capretta C, Griffith BP. Life quality in the era of bridging to cardiac transplantation: bridge patients in an outpatient selling. ASAIO J. 1993; 39:145-152.
48. Kottke TE, Pesch DG. Frye RL. The potential contribution of cardiac replacement to the control of cardiovascular diseases: a population based estimate. Arch Surg. 1990;125:1148-1151.
49. Hosenpud JD, Hennen LE, Keck BM, Fiol B, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: fourteenth official report-1997. J Heart Lung Transplant. 1997; 16:691-712.
50. 201T1 imaging in detection of myocardtal viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation. 1993;87:1630-1641.
51. Parrillo JE, Cunnion RE, Epstein SE, Parker MM, Suffredini AF, Brenner M, Schaer GL, Palmeri ST, Cannon RO III, Ailing D, Wines JT, Ferrans VJ, Rodriguez ER, Fauci AS. A prospective, randomized controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med. 1989;321:1061-1068.
52. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE. A clinical trial of immunosuppressive therapy for myocarditis: the Myocarditis Treatment Trial Investigators. N Engl J Med. 1995;333:312-313.
53. Hosenpud JD, Uretsky BF, Griffith BP, O'Connell JB, Olivari MT, Valantine HA. Successful intermediate-term outcome for patients with cardiac amyloidosis undergoing heart transplantation: results of a multicenter survey. J Heart Lung Transplant. 1990;9:346-350.
54. Keogh AM, Baron DW, Hickie JB. Prognostic guidelines in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol. 1990;65:903-908.
55. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991;83:778-786.
56. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311: 819-823.
57. Griepp RB, Stinson EB, Dong E, Clark DA, Shumway NE. Determinants of operative risk in human heart transplantation. Am J Surg. 1971;122:192-197.
58. Kormos RL, Thompson M, Hardesty RL, Griffith BP, Trento A, Uretsky BF, Reddy PS. Utility of perioperative right heart catheterization data as a predictor of survival after heart transplantation. J Heart Transplant. 1986;5:391. Abstract.
59. Kirklin JK, Naftel DC, Kirklin JW, Blackstone EH, White-Williams C, Bourge RC. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant. 1988;7:331-336.
60. Costard-Jäckle, Fowler MB. Influence of perioperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol. 1992;19:48-54.
61. O'Connell JB, Bourge RC, Costanzo-Nordin MR, Driskoll DJ, Morgan JP, Rose EA, Uretsky BF. Cardiac transplantation: recipient selection, donor procurement, and medical follow-up. Circulation. 1992;86: 1061-1079.
62. Costanzo MR, Augustine S, Bourge R, Bristow M, O'Connell JB, Driskoll D, Rose E. Selection and treatment of candidates for heart transplantation. Circulation. 1995;92:3593-3612.
63. Mudge GH, Goldstein S, Addonizio LJ, Caplan A, Mancini D, Levine TB, Ritsch ME Jr, Stevenson LW. 24th Bethesda Conference: Cardiac Transplantation: Task force 3: recipient guidelines/prioritiiation. J Am Coll Cardiol. 1993;22:21-31.
64. Carrier M, Emery RW, Riley RE, Levinson MM, Copeland JG. Cardiac transplantation in patients over 50 years of age. J Am Coll Cardiol. 1986;8:285-288.
65. Olivari MT, Antolick A, Kaye MP, Jamieson SW, Ring WS. Heart transplantation in elderly patients. J Heart Transplant. 1988;7:258-264.
66. Munoz E, Longquist J, Radovancevic B, Baldwin RT, Ford S, Duncop JM, Frazier OH. Long-term results in diabetic patients undergoing cardiac transplantation. J Heart Transplant. 1991;10:189-190.
67. Rhenman MJ, Rhenman B, Icenogle T, Christensen R, Copeland J, Diabetes and heart transplantation. J Heart Transplant. 1988:7: 356-358.
68. Ladowski J, Kormos RL, Uretsky BF, Griffith BP, Armilage JM, Hardesty RL. Heart transplantation in diabetic patients. Transplantation. 1990;49:303-305.
69. Yousem SA, Paradis IL, Dauber JH, Zeevi A, Duquesnoy RJ, Dal Col R, Armilage J, Hardesty RL, Griffith BP. Pulmonary arteriosclerosis in long-term human heart-lung transplant recipients, Transplantation. 1988;47:564-569.
70. Yousem SA, Burke CM, Billingham ME. Pathologic pulmonary alterations in long-term human heart-lung transplantation. Hum Pathol. 1985;16:911-923.
71. Fellstrom B, Larsson E, Tufveson G. Strategies in chronic rejection of transplanted organs: a current view on pathogenesis. diagnosis, and treatment. Transplant Proc. 1989;21:1435-1439.
72. Ludwig J, Baits KP, Plocy M, Rakela J, Perkins JD, Wiesner RH. Endothelitis in hepatic allografts. Mayo Clin Proc, 1989;64:545-554.
73. Adams DH, Wang L, Hubscher SG, Neubereger JM. Hepatic endothelial cells: targets in liver allograft rejection? Transplantation. 1989;47: 479-482.
74. Gao SZ, Alderman EL, Schroeder JS, Silverman JF, Hunt SA. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cordiol. 1988;12:334-340.
75. Keogh AM, Valantine HA, Hunt SA, Schroeder JS, McIntosh N, Oyer PE, Stinson EB. Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation. J Heart Lung Transplant. 1992;11:892-901.
76. Schroeder JS, Gao SZ, Alderman EL, Hunt SA, Johnstone I, Boothroyd DB, Wiederhold V, Stinson EB. A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N Engl J Med. 1993;328:164-170.
77. Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM, Chia D, Terasaki PI, Sabad A, Cogert GA, Trosian K, Hamilton MA, Moriguchi JD, Kawata N, Hage A, Drinkwater DC, Stevenson LW. Effects of pravastatin on outcomes after cardiac transplantation. N Engl J Med. 1995;333:621-627.
78. Halle AA III, DiSciascio G, Massin EK, Wilson RF, Johnson MR, Sullivan HJ, Bourge RC, Kleiman NS, Miller LW, Aversano TR, Wray RB, Hunt SA, Weston MW, Davies RA, Rincon G, Crandall CC, Cowley MJ, Kubo SH, Fisher SG, Vetrovec GW. Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol. 1995;26:120-128.
79. Ensley RD, Hunt S, Taylor DO, Renlund DG, Menlove RL, Karwande SV, O'Connell JB, Barr ML, Michler RE, Copeland JG, Miller LW. Predictors of survival after repeat heart transplantation. J Heart Lung Transplant. 1992;11:142-158.
80. Council on Ethical and Judicial Affairs, American Medical Association. Ethical considerations in the allocation of organs and other scarce medical resources among patients. Arch Intern Med. 1995;155:29-40.
81. Bishop GA, Sun J, Shell AGR, McCaughan GW. High-dose/activation tolerance: a mechanism for allograft tolerance. Transplantation. 1997; 64:1377-1382.
82. Farrar DJ, Hill JD. Recovery of major organ function in patients awaiting heart transplantation with Thoratec ventricular assist devices. J Heart Lung Transplant. 1994;13:1125-1132.
83. Friedel N, Viazis P, Schiessler A, Warnecke H, Hennig E, Trittin A, Böttner W, Hetzer R. Recovery of end-organ failure during mechanical circulatory support. Eur J Cardiothorac Surg. 1992;6:519-522.
84. Dasse KA, Frazier OH, Lesniak JM, Myers T, Burnett CM, Poirier VL. Clinical responses to ventricular assistance versus transplantation in a series of bridge to transplant patients. ASAIO J. 1992;38:M622-M626.
85. Hetzer R, Hennig E, Schiessler A, Friedel N, Wamecke H, Adt M. Mechanical circulatory support and heart transplantation. J Heart Lung Transplant. 1992;11(pt 2):S175-S181.
86. Farrar DJ. Preoperative predictors of survival in patients with Thoratec ventricular assist devices as a bridge to heart transplantation: Thoratec Ventricular Assist Device Principal Investigators. J Heart Lung Transplant. 1994;13(pt 1):93-100.
87. Stevenson LW. Patient selection for mechanical bridging to transplantation. Ann Thorac Surg. 1996;61:380-387.
88. Platt JF. Approaching the clinical application of xenotransplantation. Am J Med Sci. 1997;313:315-321.
89. McCurry KR, Kooyman DL. Alvarado CG. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med. 1995;1:423-427.
90. Thompson C. Humanised pigs hearts boost xenotransplamation. Lancet. 1995;346:766.
91. Starling RC. Radical alternatives to transplantation. Curr Opin Cardiol. 1997;12:166-171.
92. Batista RJV, Santos JLV, Takeshita N, Bocchino L, Lima PN, Cunha MA. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease. J Card Surg. 1996;11:96-97.
93. Bocchi EA, Moraes AV, Bacal F, Moreira LF, Stolf N. Clinical outcome after surgical remodeling of the left ventricle in candidates for heart transplantation with idiopathic cardiomyopathy: short-term results. Circulation. 1996;94(suppl I):I-172. Abstract.
94. McCarthy PM, Starling RC, Smedira NG, Buda TM, Scalia GM, Young JB. Partial left ventriculectomy with valve repair as an alternative to cardiac transplantation. J Heart Lung Transplant. 1997;16:41. Abstract.
95. McCarthy PM, James KB, Savage RM, Vargo R, Kendall K, Harasaki H, Hobbs RE, Pashkow FJ. Implantable left ventricular assist device: approaching an alternative for end-stage heart failure: Implantable LVAD Study Group. Circulation. 1994;90(pt 2):II-83-II-86.
96. Rose EA, Goldstein DJ. Wearable long-term mechanical support for patients with end-stage heart disease: a tenable goal. Ann Thorac Surg. 1996;61:399-402.
97. Scheinin SA, Capek P, Radovancevic B, Duncan JM. McAllister HA Jr, Frazier OH. The effect of prolonged left ventricular support on myocardial histopathology in patients with end-stage cardiomyopathy. ASAIO J. 1992;38:M271-M274.
98. Frazier OH. First use of an untethered, vented electric left ventricular assist device for long-term support. Circulation. 1994;89:2908-2914.
99. Levin HR, Oz MC, Catanese KA, Rose EA, Burkhoff D. Transient normalization of systolic and diastolic function after support with a left ventricular assist device in a patient with dilated cardiomyopathy. J Heart Lung Transplant. 1996;15:840-842.
100. Nakatani S, McCarthy PM, Kottke-Marchant K, Harasaki H, James KB, Savage RM, Thomas JD. Left ventricular echocardiographic and histologic changes: impact of chronic unloading by an implantable ventricular assist device. J Am Coll Cardiol. 1996;27:894-901.
101. Frazier OH, Benedict CR, Radovancevic B, Bick RJ, Capek P, Springer WE, Maoris MP, Delgado R, Buja LM. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg. 1996;62:675-681.
102. Müller J, Wallukat G, Weng Y, Dandel M, Spiegelsberger S, Semrau S, Brandes K, Theodoridis V, Loebe M, Meyer R, Hetzer R, Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 1997;96:542-549.
103. Loebe M, Weng Y, Müller J, Dandel M, Helfmann R, Spiegelsberger S, Hetzer R. Successful mechanical circulatory support for more than two years with a left ventricular assist device in a patient with dilated cardiomyopathy. J Heart Lung Transplant. 1997;16:1176-1179.